The transplantation of fetal striatal tissue to the striatum to modify HD progression in humans has been investigated, and some favorable effects have been found [7], [8], but it does not alter the toxic effects of mutant huntingtin and has difficulties in tissue availability and viability, high risk of rejection, ethical arguments and concerns about contamination and heterogeneity of the tissues [9]. Here, HTT is linked to Huntington disease.